[1] World Health Organization. obesity and overweight, 2020.
[2] World Health Organization. World health organization obesity and overweight fact sheet, 2019.
[3] F. L. Santos, S. S. Esteves, A. da Costa Pereira, W. S. Yancy Jr, and J. P. L. Nunes. Systematic review and
Meta analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors. Obesity
reviews, 13(11):1048–66, 2012.
[4] C. Koliaki, T. Spinos, . Spinou, . E. Brinia, D. Mitsopoulou, and N. Katsilambros. Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: a scientific statement from the national lipid association nutrition and lifestyle task force. Journal of clinical lipidology, 13(5):689–711, 2018.
[5] C. F. Kirkpatrick, J. P. Bolick, P. M. Kris-Etherton, Sikand, K. E. Aspry, D. E. Soffer, and K. C. Maki. Defining the optimal dietary approach for safe, effective and sustainable weight loss in overweight and obese adults. In healthcare. Multidisciplinary Digital Publishing Institute, 6(3):73, 2019.
[6] J. M. Kim. Ketogenic diet: old treatment, new beginning. Clinical neurophysiology practice, 2:161, 2017.
[7] Z. Z. X. Leow, K. J. Guelfi, E. A. Davis, T. W. Jones, and P. A. Fournier. The glycaemic benefits of a very low carbohydrate ketogenic diet in adults with type 1 diabetes mellitus may be opposed by increased hypoglycaemia
risk and dyslipidaemia. Diabetic Medicine, 35(9):1258–1263, 2018.
[8] W. Masood P. Annamaraju and K. R. Uppaluri. Ketogenic diet. StatPearls, 2020.
[9] L. R. Saslow, S. Kim, J. J. Daubenmier, J. T. Moskowitz, S. D. Phinney, V. Goldman, and F. M. Hecht. A randomized pilot trial of a moderate carbohydrate diet compared to a very low carbohydrate diet in overweight or obese
individuals with type 2 diabetes mellitus or prediabetes. PloS one, 9(4):91027, 2014.
[10] J. T. Batch, S. P. Lamsal, M. Adkins, S. Sultan, and M. N. Ramirez. Advantages and disadvantages of the ketogenic
diet: A review article. Cureus, 12(8):9639, 2020.
[11] A Paoli, A Rubini, JS Volek, and KA. Grimaldi. Beyond weight loss: a review of the therapeutic uses of very low carbohydrate (ketogenic) diets. eur j clin nutr. Excellent Review That Explains the Role of Physiologic Ketosis
and Possible Mechanisms for Reversing Chronic Disease, 67:789–96, 2013.
[12] E. H. Kossoff, B. A. Zupec-Kania, P. E. Amark, K. R. Ballaban-Gil, A. G. Christina Bergqvist, R. Blackford,
Charlie Foundation, and the Practice Committee of the Child Neurology Society. Optimal clinical management
of children receiving the ketogenic diet. Recommendations of the International Ketogenic Diet Study Group.
Epilepsia, 50(2):304–317, 2009.
[13] FM Sacks, GA Bray, VJ Carey, SR Smith, DH Ryan, and SD Anton. et al. comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. The New England Journal of Medicine, 360:859–73, 2009.
[14] K. Sato, Y. Kashiwaya, C. A. Keon, N. Tsuchiya, M. T. King, G. K. Radda, and R. L. Veech. Insulin, ketone bodies, and mitochondrial energy transduction. The Fed- eration of American Societies for Experimental Biology, 9(8):651–658, 1995.
[15] P. Rawla, A. R. Vellipuram, S. S. Bandaru, and J. P. Raj. Euglycemic diabetic ketoacidosis: a diagnostic and
therapeutic dilemma. endocrinology. Diabetes Metabolism Case Reports, 2017(1):17–81, 2017.
[16] J. S. Volek, M. L. Fernandez, R. D. Feinman, and S. D. Phinney. Dietary carbohydrate restriction induces a
unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning, and metabolic syn-
drome. Progress in Lipid Research, 47(5):307–318, 2008.
[17] B. J. O’Neill. Effect of low-carbohydrate diets on cardiometabolic risk, insulin resistance, and metabolic syn-
drome. current opinion in endocrinology. Diabetes and Obesity, 27(5):301–307, 2020.
[18] S. Ahola-Erkkil ̈a, C. J. Carroll, K. Peltola-Mj ̈osund, V. Tulkki, I. Mattila, T. Sepp ̈anen-Laakso, and A. Suomalainen. Ketogenic diet slows down mitochondrial myopathy progression in mice. Human Molecular Genetics, 19(10):1974–1984, 2010.
[19] C. E. Forsythe, S. D. Phinney, R. D. Feinman, B. M. Volk, D. Freidenreich, E. Quann, and J. S. Volek. Limited
effect of dietary saturated fat on plasma saturated fat in the context of a low carbohydrate diet. Lipids, 45(10):947–962, 2010.
[20] J. S. Volek, S. D. Phinney, C. E. Forsythe, E. E. Quann, R. J. Wood, M. J. Puglisi, and R. D. Feinman. Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low-fat diet. Lipids, 44(4):297– 309, 2009.
[21] Y. S. Mustafa and K. A. Maulood. Protective effect of hypericum triquetrifolium aqueous extract on biochemical and histopathological parameters in hyperlipidemic male rats. Kirkuk University Journal/Scientific Studies, 14(4):63–88, 2019.
[22] P. A. Gerber and K. Berneis. Regulation of low-density lipoprotein subfractions by carbohydrates. Current Opinion in Clinical Nutrition Metabolic Care, 15(4):381–385, 2012.
[23] H. Yki-J ̈ravine. Nutritional modulation of non-alcoholic fatty liver disease and insulin resistance. Nutrients,
7(11):9127–9138, 2015.
[24] H. M. A. AL-Obaidy, S. M. Rahim, and T. O. Al-Khesraji. Antioxidant and hyperlipidemia effect of ganoderma lucidum fungus alcoholic extract in male albino rats using tritonwr 1339. Kirkuk University Journal/Scientific Studies, 14(2):232–248, 2019.
[25] Q. A. Ahmed, S. M. Rahim, and A. K. Hameed. The effect of hydroxytyrosol (hxt) and a local olive oil extract on the level of hepcidin hormone and pathological histological changes with iron deposition in the aorta resulting
from induced hyperlipidemia in male rats. Plant Archives, 20(2):1895–1902, 2020.
[26] Q. A. Ahmed, K. K. Abdullah, and H. S. K. Hassan. The effect of olive oil (oo) and hydroxytyrosol (hxt) in improving the level of sex hormones and suppressing oxidative stress and histopathological of the testes caused by hyperlipidemia in male rats. Natural Volaties Essential Oils Journal, 8(4):13072–13086, 2021.
[27] Q. A. Ahmed, S. M. Rahim, and A. K. Hameed. The effect of hydroxytyrosol (hxt) and local olive oil (loo)
on oxidative stress and histopathological changes in the liver resulting from induced hyperlipidaemia in male rats.
Aalborg Academy Journal of Medical Sciences, 5(1):43–54, 2022.
[28] C. Kosinski and F. R. Jornayvaz. Effects of ketogenic diets on cardiovascular risk factors: evidence from animal
and human studies. Nutrients, 9(5):517, 2017.
[29] L. R. Saslow, J. J. Daubenmier, J. T. Moskowitz, S. Kim, E. J. Murphy, S. D. Phinney, and F. M. Hecht. Twelve-
month outcomes of a randomized trial of a moderate carbohydrate versus very low carbohydrate diet in over weight adults with type 2 diabetes mellitus or prediabetes. Nutrition Diabetes, 7(12):1–6, 2017.
[30] A. Accurso, R. K. Bernstein, A. Dahlqvist, B. Draznin, R. D. Feinman, E. J. Fine, and M. C. Vernon. Dietary
carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutrition Metabolism, 5(1):1–8, 2008.
[31] A. L. McKenzie, S. J. Hallberg, B. C. Creighton, B. M. Volk, T. M. Link, M. K. Abner, and S. D. Phinney. A
novel intervention including individualized nutritional recommendations reduces hemoglobin a1c level, medication use, and weight in type 2 diabetes. JMIR Diabetes,2(1):6981, 2017.
[32] N. H. Bhanpuri, S. J. Hallberg, P. T. Williams, A. L. McKenzie, K. D. Ballard, W. W. Campbell, and J. S.
Volek. Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study. Cardiovascular Diabetology, 17(1):1–16, 2018.
[33] S. J. Hallberg, A. L. McKenzie, P. T. Williams, N. H. Bhanpuri, A. L. Peters, W. W. Campbell, and J. S. Volek.
Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year: an open-label,
non-randomized, controlled study. Diabetes Therapy, 9(2):583–612, 2018.
[34] Z. Z. X. Leow, K. J. Guelfi, E. A. Davis, T. W. Jones, and P. A. Fournier. The glycaemic benefits of a very low
carbohydrate ketogenic diet in adults with type 1 diabetes mellitus may be opposed by increased hypoglycaemia
risk and dyslipidaemia. Diabetic Medicine, 35(9):1258–1263, 2018.
[35] O. Snorgaard, G. M. Poulsen, H. K. Andersen, and A. Astrup. Systematic review and meta-analysis of dietary
carbohydrate restriction in patients with type 2 diabetes. BMJ Open Diabetes Research and Care, 5(1):354, 2017.
[36] J. C. Mavropoulos, W. S. Yancy, J. Hepburn, and E. C. Westman. The effects of a low carbohydrate, ketogenic
diet on the polycystic ovary syndrome: a pilot study. Nutrition Metabolism, 2(1):1–5, 2005.
[37] B. A. Gower, P. C. Chandler-Laney, F. Ovalle, L. L. Goree, R. Azziz, R. A. Desmond, and G. W. Bates.
Favourable metabolic effects of a eucaloric lowercarbohydrate diet in women with pcos. Clinical Endocrinology, 79(4):550–557, 2013.
[38] A. Paoli, L. Mancin, M. C. Giacona, A. Bianco, and M. Caprio. Effects of a ketogenic diet in overweight
women with polycystic ovary syndrome. Journal of Translational Medicine, 18(1):1–11, 2020.
[39] A. A. Gibson, R. V. Seimon, C. M. Lee, J. Ayre, J. Franklin, T. P. Markovic, and A. Sainsbury. Do ketogenic diets really suppress appetite? a systematic review and metaanalysis. Obesity Reviews, 16(1):64–76, 2015.
[40] S. Nymo, S. R. Coutinho, P. H. Eknes I. Vestbostad, J. F. Rehfeld, H. Truby, and C. Martins. Investigation of
the long-term sustainability of changes in appetite after weight loss. International Journal of Obesity, 42(8):1489–1499, 2018.
[41] A. Lyngstad, S. Nymo, S. R. Coutinho, J. F. Rehfeld, H. Truby, B. Kulseng, and C. Martins. Investigating the
effect of sex and ketosis on weight-loss-induced changes in appetite. The American Journal of Clinical Nutrition,
109(6):1511–1518, 2019.
[42] P. Sumithran, L. A. Prendergast, E. Delbridge, and Shulkes A. Kriketos A. Proietto J. Purcell, K. Ketosis and appetite-mediating nutrients and hormones after weight loss. European Journal of Clinical Nutrition,
67(7):759–764, 2013.
[43] S. E. Deemer, E. P. Plaisance, and C. Martins. Impact of ketosis on appetite regulation a review. Nutrition Research, 77:1–11, 2020.
[44] A. Paoli, G. Bosco, E. M. Camporesi, and D. Mangar. Ketosis, ketogenic diet and food intake control: a complex relationship. Frontiers in Psychology, 6:27, 2015.
[45] K. L. Harvey, L. E. Holcomb, and S. C. Kolwicz. Ketogenic diets and exercise performance. Nutrients,
11(10):2296, 2019.
[46] P. J. Cox, T. Kirk, T. Ashmore, K. Willerton, R. Evans, A. Smith, and K. Clarke. Nutritional ketosis alters fuel
preference and thereby endurance performance in athletes. Cell Metabolism, 24(2):256–268, 2016.
[47] B. Egan and J. R. Zierath. Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metabolism, 17(2):162–184, 2013.
[48] K. Durkalec-Michalski, P. M. Nowaczyk, and K. Siedzik. Effect of a four-week ketogenic diet on exercise
metabolism in crossfit-trained athletes. Journal of the International Society of Sports Nutrition, 16(1):1–15, 2019.
[49] E. K. O’neal, A. F. Smith, A. J. Heatherly, L. G. Killen, H. S. Waldman, Hollingsworth, and Y. Koh. Effects of a 3 week high-fat-low-carbohydrate diet on lipid and glucose profiles in experienced, middle-age male runners. Inter-
national Journal of Exercise Science, 12(2):786, 2019.
[50] S. D. Phinney, E. S. Horton, E. A. Sims, J. S. Hanson, E. Danforth, and B. M. Lagrange. Capacity for
moderate exercise in obese subjects after adaptation to a hypocaloric, ketogenic diet. The Journal of Clinical
Investigation, 66(5):1152–1161, 1980.
[51] I. Janssen. Evolution of sarcopenia research. Applied physiology. Nutrition and Metabolism, 35(5):707–712,
2010.
[52] L. Larsson, H. Degens, M. Li, L. Salviati, Y. I. Lee, W. Thompson, J. L. Kirkland, and M. Sandri. Sarcopenia:
Aging-related loss of muscle mass and function. Physiological Reviews, 99(1):427–511, 2019.
[53] E. Marzetti, H. A. Lees, S. E. Wohlgemuth, and C. Leeuwenburgh. Sarcopenia of aging: Underlying
cellular mechanisms and protection by calorie restrictio. BioFactors, 35(1):28–35, 2009.
[54] T. W. Rhoads, J. P. Clark, G. E. Gustafson, K. N. Miller, M. W. Conklin, T. M. DeMuth, M. E. Berres, K. W. Eli-
ceiri, L. K. Vaughan, C. W. Lary, T. M. Beasley, R. J. Colman, and R. M. Anderson. Molecular and functional networks linked to sarcopenia prevention by caloric restriction in rhesus monkeys. Cell Systems, 10(2):156–168, 2020.
[55] B.-H. Wang, Hou, Y.-Q. Lu, M.-M. Jia, T. Qiu, X.-H. Wang, Z.-X. Zhang, and Y. Jiang. Ketogenic diet attenuates neuronal injury via autophagy and mitochondrial pathways in pentylenetetrazol-kindled seizures. Brain Research, 1678:106–115, 2018.
[56] B. F. Miller, L. M. Baehr, R. V. Musci, J. J. Reid, F. F. 3rd Peelor, K. L. Hamilton, and S. C. Bodine. Muscle-specific changes in protein synthesis with aging and reloading after disuse atrophy. Journal of Cachexia, Sarcopenia and Muscle, 10(6):1195–1209, 2019.
[57] S. L. H. Bennett, A. H. Smith, J. L. Ramirez, and D. M. Thomson. Effects of ketogenic diet on p70s6k phosphorylation in young adult and old soleus muscle. Journal of the Federation of American Societies for Experimental Biology, 33(1):558–558, 2019.
[58] M. A. Wallace, N. W. Aguirre, G. R. Marcotte, A. G. Marshall, L. M. Baehr, D. C. Hughes, and K. Baar. The
ketogenic diet preserves skeletal muscle with aging in mice. Aging Cell, 20(4):13322, 2021.
[59] J. D. Browning, J. A. Baker, T. Rogers, J. Davis, S. Satapati, and S. C. Burgess. Short-term weight loss and hepatictriglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. The American journal of Clinical Nutrition, 93(5):1048–1052, 2011.
[60] J. Ding, X. Xu, X. Wu, Huang, G. Kong, J. Liu, and Q. Zhu. Bone loss and biomechanical reduction of appen-
dicular and axial bones under ketogenic diet in rats. Experimental and Therapeutic Medicine, 17(4):2503–2510,
2019.
[61] X. Wu, Z. Huang, X. Wang, Z. Fu, J. Liu, Z. Huang, and Q. Zhu. Ketogenic diet compromises both cancellous and cortical bone mass in mice. Calcified Tissue International, 101(4):412–421, 2017.
[62] P. J. Simm, J. Bicknell-Royle, J. Lawrie, J. Nation, K. Draffin, K. G. Stewart, and M. T. Mackay. The effect
of the ketogenic diet on the developing skeleton. Epilepsy Research, 136:62–66, 2017.
[63] K. H. Lauritzen, M. M. Hasan-Olive, C. E. Regnell, L. Kleppa, M. Scheibye-Knudsen, A. Gjedde, and L. H.
Bergersen. A ketogenic diet accelerates neurodegeneration in mice with induced mitochondrial dna toxicity in
the forebrain. Neurobiology of Aging, 48:34–47, 2016.
[64] M. A. McNally, P. L. Pyzik, J. E. Rubenstein, R. F. Hamdy, and E. H. Kossoff. Empiric use of potassium
citrate reduces kidney-stone incidence with the ketogenic diet. Pediatrics, 124(2):300–304, 2009.
[65] M. Marchi `o, L. Roli, C. Lucchi, A. M. Costa, M. Borghi, L. Iughetti, and G. Biagini. Ghrelin plasma levels after 1 year of ketogenic diet in children with refractory epilepsy. Frontiers in Nutrition, 6:112, 2019